The state of the biopharma industry is being examined, with a focus on what 2025 may hold. Various aspects of the industry are being explored, including therapeutic area advances, clinical trials trends, and the role of artificial intelligence and data science. The industry's future is also being considered in terms of funding, mergers and acquisitions, and partnering, as well as the potential operational transformation driven by ai.